As the global economy mends, the 2021 growth of Pharmaceutical Development Preclinical CRO will have significant change from previous year. According to our (LP Information) latest study, the global Pharmaceutical Development Preclinical CRO market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pharmaceutical Development Preclinical CRO market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Pharmaceutical Development Preclinical CRO market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pharmaceutical Development Preclinical CRO market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Development Preclinical CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pharmaceutical Development Preclinical CRO players cover Charles River, Wuxi AppTec, Labcorp, and Eurofins Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Development Preclinical CRO market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology